UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 18, 2005
Airtrax, Inc.
(Exact name of registrant as specified in its charter)
New Jersey 0-25791 22-3506376
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
200 Freeway Drive Unit One, Blackwood, NJ 08012
(Address of principal executive offices and Zip Code)
Registrant's telephone number, including area code (856) 232-3000
Copies to:
Richard A. Friedman
Eric A. Pinero, Esq.
Sichenzia Ross Friedman Ference LLP
1065 Avenue of the Americas
New York, New York 10018
Phone: (212) 930-9700
Fax: (212) 930-9725
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On October 18, 2005, we entered into a 8% Series C Unsecured Convertible
Debenture and Warrants Purchase Agreement (the "Purchase Agreement") with
certain accredited investors pursuant to which we sold an aggregate of
$1,000,000 principal amount unsecured convertible debentures (the "Debentures")
convertible into shares of our common stock, no par value (the "Common Stock"),
and stock purchase warrants (the "Warrants") to purchase shares of our Common
Stock to certain accredited investors who are parties to the Purchase Agreement
(the "Investors") for an aggregate purchase price of $1,000,000.
The Debentures mature on October 18, 2007; provided, however, that if our Common
Stock is trading at a closing bid price of less than $2.00 on said maturity
date, the maturity date shall be extended to April 18, 2008. Provided there then
exists no event of default by us under the Debentures, the principal of and any
accrued but unpaid interest due under the Debentures on the maturity date shall
automatically be converted into shares of Common Stock on the maturity date at
the then applicable conversion price. The Debentures pay simple interest
quarterly accruing at the annual rate of 8%, either in the form of our Common
Stock, which shall be valued and computed based upon the lower of (i) $2.00, or
(ii) eighty five (85%) percent the average closing price for our Common Stock
for the 10 trading days prior to the payment due date, or cash, each at our
option. The Debentures are convertible into shares of our Common Stock at a
conversion price equal to $2.00, subject to adjustment in certain events,
including, without limitation, upon our consolidation, merger or sale of all of
substantially all of our assets, a reclassification of our Common Stock, or any
stock splits, combinations or dividends with respect to our Common Stock. We may
in our discretion require that the Investors convert all or a portion of the
Debentures and we may also redeem the Debentures at a price equal to 120% of the
principal balance and accrued interest thereon that are requested to be
redeemed.
In addition, we issued 500,000 Warrants to the Investors, representing an amount
of Warrants equal to 100% of the quotient of (i) the principal amount of the
Debentures issued at the closing date divided by (ii) the conversion price on
the closing date. The Warrants are exercisable at a price equal to $3.25, from
the date of issuance until 5 years after the closing date, subject to adjustment
in certain events, including, without limitation, upon our consolidation, merger
or sale of all of substantially all of our assets, a reclassification of our
Common Stock, or any stock splits, combinations or dividends with respect to our
Common Stock.
Under the Registration Rights Agreement we entered into with the Investors on
October 18, 2005, we are obligated to file a registration statement on Form SB-2
to effect the registration of 200% the Common Stock issuable upon conversion of
the Debentures and exercise of the Warrants within 150 days after October 18,
2005. We are obligated to use our best efforts to cause the registration
statement to be declared effective no later than 35 days after the filing date.
If we do not file the registration statement, or if the registration statement
is not declared effective by the SEC, each within the deadlines specified in the
preceding sentence, we shall pay to the Investors, as liquidated damages, an
amount equal to 2% of the amount invested by the Investors on a pro rata basis
for each 30-day period of such registration default. However, we shall only be
required pay liquidated damages, if any, to the Investors for a total of 9
months, either in the aggregate or for 9 consecutive months.
Further, we paid commissions of $100,000, a non-accountable expense allowance of
$30,000, and issued 50,000 Warrants to the placement agent, a registered broker
dealer firm, each as consideration for services performed in connection with the
issuance of the Debentures and Warrants to the Investors pursuant to the
Purchase Agreement. The placement agent has no obligation to buy any Debentures
or Warrants from us. In addition, we have agreed to indemnify the placement
agent and other persons against specific liabilities under the Securities Act of
1933, as amended.
We claim an exemption from the registration requirements of the Act for the
private placement of these securities pursuant to Section 4(2) of the Act and/or
Regulation D promulgated thereunder since, among other things, the transaction
did not involve a public offering, the Investors were accredited investors
and/or qualified institutional buyers, the Investors had access to information
about us and their investment, the Investors took the securities for investment
and not resale, and we took appropriate measures to restrict the transfer of the
securities.
2
Item 2.03 Creation of a Direct Financial Obligation.
See Item 1.01 above.
Item 3.02 Unregistered Sales of Equity Securities.
See Item 1.01 above.
Item 9.01 Financial Statements and Exhibits.
(a) Financial statements of business acquired.
Not applicable.
(b) Pro forma financial information.
Not applicable.
(c) Exhibits.
Exhibit Number Description
--------------- ---------------------------------------------------------------
10.1 8% Series C Unsecured Convertible Debenture and Warrants
Purchase Agreement, dated October 18, 2005, by and between
Airtrax, Inc. and the investors named on the signature pages
thereto.
10.2 Registration Rights Agreement dated October 18, 2005, by and
between Airtrax, Inc. and the investors named on the
signature pages thereto.
10.3 Form of 8% Series C Unsecured Convertible Debenture of
Airtrax, Inc.
10.4 Form of Stock Purchase Warrant of Airtrax, Inc.
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Airtrax, Inc.
Date: October 24, 2005 /s/ Peter Amico
---------------
Peter Amico
Chief Executive Officer